Salkind Gene's Form 4 filing
Upexi, Inc. (UPXI) · filed Jul 30, 2025
- Accession no.
- 0001477932-25-005338
- Filed
- Jul 30, 2025
- Trade date
- Jul 11-16, 2025
- Filing delay
- 19 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $100.0K. It was filed 19 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Salkind GeneCIK 0001592481 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 11, 2025 | Common Stock | PPurchaseAcquired | +20,243 | $4.94 | +$100,000.42 | 385,370 | Direct | |
| Jul 16, 2025 | Common Stock | AGrant or awardAcquired | +50,000 | $0.00 | $0 | 435,370 | Direct | |
| Jul 16, 2025 | Common Stock | AGrant or awardAcquired | +150,000 | $0.00 | $0 | 585,370 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.